VISION SOURCE

Vision Source has franchised since 1996 under parent EssilorLuxottica, growing modestly from 2,999 locations in 2024 to 3,027 in 2025—a mere +1% trajectory signaling maturity rather than explosive expansion. Projections show 219 new units planned, but health metrics flag concerns: 79 terminations, 54 non-renewals, and 31 transfers suggest some doctors are exiting the network. Litigation is limited to four franchisor-initiated collection suits, a minor blemish for a system this size. Item 20 data portrays a stable but not surging cooperative, ideal for established optometrists seeking leverage without full corporate oversight.

Financials start with a $100,000-$450,000 initial investment, accessible compared to medical peers, paired with a 2.5% royalty capped at $48,000 annually per office—no ad fund or fixed monthly fees sweeten the deal. Notably, no Item 19 disclosure means no official earnings claims, forcing reliance on indirect signals: 34 SBA loans averaging $677,038 with a low 2.9% default rate indicate viable financing and franchisee confidence. Without revenue transparency, profitability hinges on leveraging the network's discounts and marketing; for a high-margin eyewear retail model, this could yield solid returns, but vet thoroughly as system churn tempers the optimism.